ArticleDrug design, development and therapy2022

Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma.

Hongyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.